HeartSciences Inc. is a medical technology company that develops AI-based solutions to enhance the clinical utility of electrocardiograms (ECGs). The company focuses on improving healthcare delivery, particularly in frontline clinical settings, by providing a cloud-based platform for AI-ECG algorithms and a low-cost ECG hardware solution. Its primary product candidate, the MyoVista® wavECG™, is a 12-lead ECG device designed to deliver diagnostic insights on cardiac dysfunction, traditionally available only through advanced imaging techniques. HeartSciences serves healthcare providers and clinicians, aiming to facilitate early detection of heart disease.
No recent RNS announcements for HSCS across HSCS, HSCSW.
No recent RNS announcements for HSCS across HSCS, HSCSW.